EconPapers    
Economics at your fingertips  
 

Pharmaco-metabonomic phenotyping and personalized drug treatment

T. Andrew Clayton, John C. Lindon, Olivier Cloarec, Henrik Antti, Claude Charuel, Gilles Hanton, Jean-Pierre Provost, Jean-Loïc Le Net, David Baker, Rosalind J. Walley, Jeremy R. Everett and Jeremy K. Nicholson ()
Additional contact information
T. Andrew Clayton: Sir Alexander Fleming Building, Imperial College London
John C. Lindon: Sir Alexander Fleming Building, Imperial College London
Olivier Cloarec: Sir Alexander Fleming Building, Imperial College London
Henrik Antti: Umeå University
Claude Charuel: Centre de Recherche
Gilles Hanton: Centre de Recherche
Jean-Pierre Provost: Centre de Recherche
Jean-Loïc Le Net: Centre de Recherche
David Baker: Pfizer Inc.
Rosalind J. Walley: Pfizer Global Research & Development
Jeremy R. Everett: Pfizer Global Research & Development
Jeremy K. Nicholson: Sir Alexander Fleming Building, Imperial College London

Nature, 2006, vol. 440, issue 7087, 1073-1077

Abstract: Medicines for one We may one day benefit from 'personalized medicine', which will involve analysing key characteristics of an individual and predicting which drugs will be effective for that patient. Although the pharmacogenomic approach looked promising, its usefulness is limited as it does not take account of potentially important environmental factors. Enter 'pharmaco-metabonomics', which uses a combination of pre-dose metabolite profiling and chemometrics to model and predict the response of an individual. A 'proof-of-principle' for this approach, in which the metabolic effects of paracetamol in rats were predicted, is published this week. This approach involves the analysis of a patient's metabolic phenotype, which is influenced not only by genotype but also by factors such as nutritional status, age and disease, so it could be an important step towards personalized human healthcare.

Date: 2006
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.nature.com/articles/nature04648 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:440:y:2006:i:7087:d:10.1038_nature04648

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature04648

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:440:y:2006:i:7087:d:10.1038_nature04648